Total Receivables - Bergenbio ASA (OSE:BGBIO) - Alpha Spread
B

Bergenbio ASA
OSE:BGBIO

Watchlist Manager
Bergenbio ASA
OSE:BGBIO
Watchlist
Price: 9.07 NOK 1.06% Market Closed
Market Cap: 368.3m NOK
Have any thoughts about
Bergenbio ASA?
Write Note

Bergenbio ASA
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bergenbio ASA
Total Receivables Peer Comparison

Comparables:
HBC
L
LYTIX
AZT
N
NYKD
T
TRMED

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
B
Bergenbio ASA
OSE:BGBIO
Total Receivables
kr11.1m
CAGR 3-Years
2%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Total Receivables
kr23.4m
CAGR 3-Years
11%
CAGR 5-Years
13%
CAGR 10-Years
-7%
L
Lytix Biopharma AS
OSE:LYTIX
Total Receivables
kr12.8m
CAGR 3-Years
45%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Total Receivables
kr26.9m
CAGR 3-Years
0%
CAGR 5-Years
15%
CAGR 10-Years
14%
N
Nykode Therapeutics ASA
OSE:NYKD
Total Receivables
$4.5m
CAGR 3-Years
-38%
CAGR 5-Years
34%
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Total Receivables
kr3.6m
CAGR 3-Years
-38%
CAGR 5-Years
-34%
CAGR 10-Years
N/A

See Also

What is Bergenbio ASA's Total Receivables?
Total Receivables
11.1m NOK

Based on the financial report for Mar 31, 2024, Bergenbio ASA's Total Receivables amounts to 11.1m NOK.

What is Bergenbio ASA's Total Receivables growth rate?
Total Receivables CAGR 5Y
-16%

Over the last year, the Total Receivables growth was 8%. The average annual Total Receivables growth rates for Bergenbio ASA have been 2% over the past three years , -16% over the past five years .

Back to Top